financetom
Business
financetom
/
Business
/
Ortoli Rosenstadt LLP Announces its Partner Jason Ye Joining Ownership Group of the Brisbane Bullets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ortoli Rosenstadt LLP Announces its Partner Jason Ye Joining Ownership Group of the Brisbane Bullets
Nov 13, 2025 6:49 AM

New York, NY, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ortoli Rosenstadt LLP (“OR”) is proud to announce that its Partner Jason Ye has acquired a minority ownership stake in the Brisbane Bullets, a premier team in Australia’s National Basketball League (NBL).

This strategic investment marks a significant milestone in OR’s international expansion, complementing the firm’s earlier opening of its Singapore office and its more recent launch in Hong Kong, placing the firm at the leading edge of a fast-evolving market and reinforcing its commitment to deepening its business footprint and professional network across the Asia-Pacific region. With Mr. Ye’s entry into the Australian sports and entertainment market ahead of the Brisbane 2032 Olympics, the firm continues to execute its vision on building bridges between global capital and emerging opportunities worldwide in various dynamic industries and sectors.

“Jason’s acceptance into the Brisbane Bullets ownership group goes beyond personal success—it exemplifies our management team’s entrepreneurship and firm’s global reach,” said William Rosenstadt, OR Founding and Managing Partner. “Australia’s vibrant economy and its rapidly growing sports and entertainment industry present exciting prospects for our international clientele.  We see this as a gateway to future opportunities that will complement and enhance the services we already provide worldwide. We’re confident that Jason will harness this new network to create meaningful synergies for the clients we represent.”

As firm’s Asia Practice Co-Chair and the Managing Partner of its Singapore and Hong Kong offices, Mr. Ye joins an elite group of established sports executives and investors that includes the team’s long-time owner Jason Levien and several high-profile current and former NBA figures, underscoring the Brisbane Bullets’ rising prominence and international appeal. Mr. Ye’s inclusion in this distinguished circle signals the recognition of his individual accomplishment, as well as a new era of cross-border collaboration and innovation between capital markets and sports ownership.

“I am honored to be accepted as part of the Brisbane Bullets family and play a role in advancing the team’s success both on and off the court,” said Jason Ye. “Brisbane is a thriving city of over 2.5 million people, with a vibrant Asian community that resonates deeply with my own background. Basketball is a truly global sport, and this investment embodies both my love for the sport and dedication to cultivating impactful global partnerships. I am excited to leverage this opportunity to enhance the Brisbane Bullets’ presence within the city’s Asian community and help expand the team’s reach across Asia and on the international stage.”

Ortoli Rosenstadt LLP congratulates Mr. Ye on this exciting new chapter and looks forward to supporting the continued success of the Brisbane Bullets and the broader Australian business and sports community. This transaction was facilitated and supported by lawyers at Ortoli Rosenstadt Ye LLP (Hong Kong), underscoring the firm’s cross-border capabilities and highlighting its integrated approach to global deal-making for clients across jurisdictions.

About Ortoli Rosenstadt LLP

Founded in 2006, Ortoli Rosenstadt is a New York-based law firm representing global clients. The firm provides cutting-edge, solution-oriented legal advice to its clients in a wide variety of practice areas, including corporate & securities, mergers and acquisitions, private equity, real estate, employment, intellectual property, and litigation.

PRESS CONTACT:

[email protected]

212-588-0022

Image: https://www.globenewswire.com/newsroom/ti?nf=OTU3NTE5MCM3MjYyNjQ4IzUwMDExMjM1OQ==

Image: https://ml.globenewswire.com/media/NWQ2NjVlMDQtZGMwOC00Mjg0LTgzOTUtZTc2NTkwN2M1MzY4LTUwMDExMjM1OS0yMDI1LTExLTEzLWVu/tiny/Ortoli-Rosenstadt-LLP.png Image: Primary Logo

Source: Ortoli Rosenstadt LLP

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bowhead Specialty Holdings Reports Q3 Preliminary Adjusted Earnings
Bowhead Specialty Holdings Reports Q3 Preliminary Adjusted Earnings
Oct 22, 2024
05:13 AM EDT, 10/22/2024 (MT Newswires) -- Bowhead Specialty Holdings ( BOW ) reported Q3 preliminary adjusted earnings Monday of $0.36 to $0.39 per diluted share. Analysts polled by Capital IQ expect $0.33. The company's share price fell almost 5% aftermarket hours on Monday. Price: 29.10, Change: -1.46, Percent Change: -4.78 ...
Cheesecake Factory Shares Jumps In Pre-Market After Activist Investor Reportedly Pushes For Strategic Breakup
Cheesecake Factory Shares Jumps In Pre-Market After Activist Investor Reportedly Pushes For Strategic Breakup
Oct 22, 2024
A week before releasing its earnings report, an activist investor has taken a stake in Cheesecake Factory ( CAKE ) and is reportedly urging the company to spin off three smaller brands into a separate public entity. Following the report, the company shot up during the pre-market. What Happened: According to Benzinga Pro, Cheesecake Factory ( CAKE ) traded 4.64% higher at $44.42 during the...
Molecular Partners, Orano Med Report Positive Preclinical Data on MP0712
Molecular Partners, Orano Med Report Positive Preclinical Data on MP0712
Oct 22, 2024
05:05 AM EDT, 10/22/2024 (MT Newswires) -- Molecular Partners ( MOLN ) and Orano Med said Tuesday that the latest preclinical data on their MP0712 product candidate confirmed high tumor uptake while keeping low kidney exposure. The companies co-developed MP0712 as a radio-designed ankyrin repeat protein therapeutic candidate that targets delta-like ligand 3, according to the statement. Molecular Partners (...
'Open banking' rules for consumer data unveiled by US watchdog
'Open banking' rules for consumer data unveiled by US watchdog
Oct 22, 2024
(Reuters) - The top U.S. watchdog agency for consumer financial protection on Tuesday unveiled long-awaited rules intended to drive a shift toward open banking and spur competition, allowing consumers to control and share their own data when shopping for services. The new rules also aim to govern relations between the burgeoning world of financial technology companies that offer consumer apps...
Copyright 2023-2026 - www.financetom.com All Rights Reserved